Capital Planning Advisors’s Merck MRK Stock Holding History

Capital Planning Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.4M	Sell	11,665 -464	-4%	-$53.6K	0.2%	69
2025 Q4	$1.28M	Buy	12,129 +5,570	+85%	+$523K	0.17%	79
2025 Q3	$550K	Sell	6,559 -5,466	-45%	-$450K	0.08%	107
2025 Q2	$952K	Sell	12,025 -14,084	-54%	-$1.12M	0.14%	79
2025 Q1	$2.34M	Sell	26,109 -7,322	-22%	-$684K	0.36%	55
2024 Q4	$3.33M	Sell	33,431 -11,858	-26%	-$1.22M	0.51%	47
2024 Q3	$5.14M	Buy	45,289 +2,691	+6%	+$320K	0.78%	34
2024 Q2	$5.27M	Buy	42,598 +888	+2%	+$114K	0.9%	29
2024 Q1	$5.5M	Buy	41,710 +1,158	+3%	+$143K	0.97%	26
2023 Q4	$4.42M	Buy	40,552 +589	+1%	+$61.1K	0.84%	31
2023 Q3	$4.11M	Sell	39,963 -42	-0.1%	-$4.53K	0.86%	30
2023 Q2	$4.62M	Sell	40,005 -670	-2%	-$76.1K	0.94%	26
2023 Q1	$4.33M	Sell	40,675 -554	-1%	-$59.8K	0.92%	30
2022 Q4	$4.57M	Buy	41,229 +170	+0.4%	+$17.4K	1.09%	26
2022 Q3	$3.54M	Buy	41,059 +22,767	+124%	+$2.03M	0.95%	29
2022 Q2	$1.67M	Buy	18,292 +14	+0.1%	+$1.24K	0.44%	52
2022 Q1	$1.5M	Buy	18,278 +20	+0.1%	+$1.58K	0.32%	70
2021 Q4	$1.4M	Sell	18,258 -1,540	-8%	-$123K	0.27%	75
2021 Q3	$1.49M	Sell	19,798 -15,340	-44%	-$1.17M	0.31%	73
2021 Q2	$2.73M	Sell	35,138 -5,250	-13%	-$390K	0.56%	48
2021 Q1	$2.97M	Buy	40,388 +2,945	+8%	+$217K	0.67%	44
2020 Q4	$2.92M	Sell	37,443 -503	-1%	-$38.5K	0.72%	36
2020 Q3	$3M	Buy	37,946 +154	+0.4%	+$12.1K	0.82%	35
2020 Q2	$2.79M	Buy	37,792 +3,359	+10%	+$253K	0.83%	34
2020 Q1	$2.53M	Sell	34,433 -561	-2%	-$44.1K	0.94%	37
2019 Q4	$3.04M	Buy	34,994 +1,833	+6%	+$151K	0.79%	48
2019 Q3	$2.66M	Sell	33,161 -373	-1%	-$29.9K	0.78%	44
2019 Q2	$2.68M	Buy	33,534 +833	+3%	+$63.8K	0.79%	44
2019 Q1	$2.6M	Sell	32,701 -938	-3%	-$70.2K	0.79%	42
2018 Q4	$2.45M	Buy	33,639 +921	+3%	+$65K	0.89%	37
2018 Q3	$2.21M	Buy	32,718 +21,293	+186%	+$1.36M	0.71%	46
2018 Q2	$662K	Buy	+11,425	New	+$645K	0.3%	69
2018 Q1	–	Sell	-4,003	Closed	-$215K	–	125
2017 Q4	$215K	Buy	+4,003	New	+$222K	0.08%	118
2017 Q3	–	Sell	-3,819	Closed	-$234K	–	131
2017 Q2	$234K	Sell	3,819 -3,934	-51%	-$239K	0.1%	119
2017 Q1	$470K	Hold	7,753	–	–	0.23%	78
2016 Q4	$436K	Sell	7,753 -18,647	-71%	-$1.09M	0.23%	72
2016 Q3	$1.57M	Hold	26,400	–	–	0.84%	31
2016 Q2	$1.45M	Hold	26,400	–	–	0.81%	32
2016 Q1	$1.33M	Sell	26,400 -133	-0.5%	-$6.51K	0.64%	31
2015 Q4	$1.34M	Buy	26,533 +17,436	+192%	+$879K	0.78%	30
2015 Q3	$429K	Buy	9,097 +923	+11%	+$49K	0.28%	67
2015 Q2	$444K	Buy	8,174 +366	+5%	+$20.5K	0.26%	71
2015 Q1	$428K	Buy	7,808 +1,520	+24%	+$86.1K	0.3%	59
2014 Q4	$341K	Buy	+6,288	New	+$350K	0.3%	65

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Planning Advisors's MRK Position: Q1 2026 in Review

Capital Planning Advisors reduced its Merck (MRK) stake by 3.8% in Q1 2026, selling an estimated $53.6K and leaving 11,665 shares worth $1.4M. The position accounts for 0.2% of the portfolio, ranked #69.

Capital Planning Advisors first reported a position in MRK in Q4 2014 and has held it in 44 quarters since. The position peaked at $5.5M in Q1 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Capital Planning Advisors held 11,665 shares of Merck worth $1.4M as of Q1 2026.
Capital Planning Advisors sold 464 Merck shares in Q1 2026, an estimated $53.6K.
Merck made up 0.2% of Capital Planning Advisors's portfolio in Q1 2026, its #69 holding.
Capital Planning Advisors first reported a position in Merck in Q4 2014 and has held it in 44 quarters since.
Capital Planning Advisors's Merck position peaked at $5.5M in Q1 2024.
3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Capital Planning Advisors's 13F filing for Q1 2026, filed 14 May 2026.